186 related articles for article (PubMed ID: 2841493)
21. Glucocorticoids facilitate the stable transformation of embryonal rat fibroblasts by a polyomavirus large tumor antigen-deficient mutant.
Martens I; Nilsson M; Magnusson G; Linder S
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5571-5. PubMed ID: 2840668
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of polyoma T antigens.
Schaffhausen BS; Benjamin TL
Cell; 1979 Dec; 18(4):935-46. PubMed ID: 229974
[TBL] [Abstract][Full Text] [Related]
23. Polyomavirus middle T-antigen NPTY mutants.
Druker BJ; Sibert L; Roberts TM
J Virol; 1992 Oct; 66(10):5770-6. PubMed ID: 1326642
[TBL] [Abstract][Full Text] [Related]
24. The p110alpha isoform of phosphatidylinositol 3-kinase is essential for polyomavirus middle T antigen-mediated transformation.
Utermark T; Schaffhausen BS; Roberts TM; Zhao JJ
J Virol; 2007 Jul; 81(13):7069-76. PubMed ID: 17442716
[TBL] [Abstract][Full Text] [Related]
25. Isolation and characterization of NIH 3T3 cells expressing polyomavirus small T antigen.
Noda T; Satake M; Robins T; Ito Y
J Virol; 1986 Oct; 60(1):105-13. PubMed ID: 3018277
[TBL] [Abstract][Full Text] [Related]
26. Transformation-defective polyoma middle T antigen mutants defective in PLCgamma, PI-3, or src kinase activation enhance ERK2 activation and promote retinoic acid-induced, cell differentiation like wild-type middle T.
Yen A; Cherington V; Schaffhausen B; Marks K; Varvayanis S
Exp Cell Res; 1999 May; 248(2):538-51. PubMed ID: 10222145
[TBL] [Abstract][Full Text] [Related]
27. Interactions between polyomavirus medium T antigen and three cellular proteins of 88, 61, and 37 kilodaltons.
Grussenmeyer T; Carbone-Wiley A; Scheidtmann KH; Walter G
J Virol; 1987 Dec; 61(12):3902-9. PubMed ID: 2824823
[TBL] [Abstract][Full Text] [Related]
28. Characterization of polyoma mutants with altered middle and large T-antigens.
Magnusson G; Nilsson MG; Dilworth SM; Smolar N
J Virol; 1981 Sep; 39(3):673-83. PubMed ID: 6270343
[TBL] [Abstract][Full Text] [Related]
29. Transformation and tumorigenic properties of a mutant polyomavirus containing a middle T antigen defective in Shc binding.
Yi X; Peterson J; Freund R
J Virol; 1997 Sep; 71(9):6279-86. PubMed ID: 9261344
[TBL] [Abstract][Full Text] [Related]
30. Transformation by polyoma virus middle T antigen.
Courtneidge SA
Cancer Surv; 1986; 5(2):173-82. PubMed ID: 2430702
[TBL] [Abstract][Full Text] [Related]
31. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity.
Kaplan DR; Whitman M; Schaffhausen B; Pallas DC; White M; Cantley L; Roberts TM
Cell; 1987 Sep; 50(7):1021-9. PubMed ID: 2441878
[TBL] [Abstract][Full Text] [Related]
32. Oncogenes and phosphatidylinositol turnover.
Cantley LC; Whitman M; Chahwala S; Fleischman L; Kaplan DR; Schaffhausen BS; Roberts TM
Ann N Y Acad Sci; 1986; 488():481-90. PubMed ID: 2437850
[TBL] [Abstract][Full Text] [Related]
33. Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation.
Jelinek MA; Hassell JA
Oncogene; 1992 Sep; 7(9):1687-98. PubMed ID: 1380149
[TBL] [Abstract][Full Text] [Related]
34. Further characterisation of the complex containing middle T antigen and pp60.
Courtneidge SA
Curr Top Microbiol Immunol; 1989; 144():121-8. PubMed ID: 2477198
[No Abstract] [Full Text] [Related]
35. In vitro mutagenesis of the putative membrane-binding domain of polyomavirus middle-T antigen.
Markland W; Cheng SH; Oostra BA; Smith AE
J Virol; 1986 Jul; 59(1):82-9. PubMed ID: 2423706
[TBL] [Abstract][Full Text] [Related]
36. Site-directed mutagenesis of polyomavirus middle-T antigen sequences encoding tyrosine 315 and tyrosine 250.
Markland W; Oostra BA; Harvey R; Markham AF; Colledge WH; Smith AE
J Virol; 1986 Aug; 59(2):384-91. PubMed ID: 2426465
[TBL] [Abstract][Full Text] [Related]
37. Inositol trisphosphate levels in cells expressing wild-type and mutant polyomavirus middle T antigens: evidence for activation of phospholipase C via activation of pp60c-src.
Gorga FR; Riney CE; Benjamin TL
J Virol; 1990 Jan; 64(1):105-12. PubMed ID: 2152807
[TBL] [Abstract][Full Text] [Related]
38. Suppression of AP-1 constitutive activity interferes with polyomavirus MT antigen transformation ability.
Winnischofer SM; de Oliveira ML; Sogayar MC
J Cell Biochem; 2003 Oct; 90(2):253-66. PubMed ID: 14505342
[TBL] [Abstract][Full Text] [Related]
39. Binding of p53 and p105-RB is not sufficient for oncogenic transformation by a hybrid polyomavirus-simian virus 40 large T antigen.
Manfredi JJ; Prives C
J Virol; 1990 Nov; 64(11):5250-9. PubMed ID: 2214017
[TBL] [Abstract][Full Text] [Related]
40. Primary rat cells expressing a hybrid polyomavirus-simian virus 40 large T antigen have altered growth properties.
Manfredi JJ; Prives C
J Virol; 1993 Aug; 67(8):4750-9. PubMed ID: 8392612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
